MRI of the joint and evaluation of the granulocyte–macrophage colony-stimulating factor–CCL17 axis in patients with rheumatoid arthritis receiving otilimab: a phase 2a randomised mechanistic study

Genovese, MC, Berkowitz, M, Conaghan, PG orcid.org/0000-0002-3478-5665 et al. (14 more authors) (2020) MRI of the joint and evaluation of the granulocyte–macrophage colony-stimulating factor–CCL17 axis in patients with rheumatoid arthritis receiving otilimab: a phase 2a randomised mechanistic study. Lancet Rheumatology, 2 (11). e666-e676. ISSN 2665-9913

Abstract

Metadata

Authors/Creators:
  • Genovese, MC
  • Berkowitz, M
  • Conaghan, PG ORCID logo https://orcid.org/0000-0002-3478-5665
  • Peterfy, C
  • Davy, K
  • Fisheleva, E
  • Gupta, A
  • Inman, D
  • Janiczek, R
  • Layton, M
  • Mitchell, N
  • Patel, J
  • Roberts, A
  • Saurigny, D
  • Smith, JE
  • Williamson, R
  • Tak, PP
Copyright, Publisher and Additional Information: © 2020, Elsevier Ltd. All rights reserved. This is an author produced version of an article published in The Lancet Rheumatology. Uploaded in accordance with the publisher's self-archiving policy.
Dates:
  • Accepted: 25 June 2020
  • Published (online): 7 October 2020
  • Published: November 2020
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Musculoskeletal Medicine & Imaging (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 03 Jul 2020 13:03
Last Modified: 06 Apr 2021 00:38
Status: Published
Publisher: Elsevier
Identification Number: https://doi.org/10.1016/S2665-9913(20)30224-1

Share / Export

Statistics